NCT07121491

Brief Summary

This study compared the labour outcomes and childbirth experience between Zhang and WHO partograph.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
713

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 27, 2024

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 28, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 24, 2025

Completed
20 days until next milestone

First Posted

Study publicly available on registry

August 13, 2025

Completed
Last Updated

August 13, 2025

Status Verified

August 1, 2025

Enrollment Period

8 months

First QC Date

July 24, 2025

Last Update Submit

August 9, 2025

Conditions

Outcome, Adverse BirthChildbirth Experience

Keywords

Labour outcomeChildbirth experience

Outcome Measures

Primary Outcomes (1)

  • Caesarean section rate

    Rate of delivery via caesarean section in percentage

    from cervical dilatation of 4 or 6 cm through study completion up to delivery of the foetus

Secondary Outcomes (1)

  • Childbirth experience

    from Day 1 throughout study completion, an average of 7 days after delivery

Other Outcomes (5)

  • Use of analgesia

    From cervical dilatation of 4 or 6 cm until delivery of fetus

  • Oxytocin use

    From cervical dilatation of 4 or 6 cm until delivery of fetus

  • Duration of hospital stay

    From predelivery throughout study completion, an average of 5 days

  • +2 more other outcomes

Study Arms (2)

Cervical dilatation 4 cm

Women with cervical dilatation 4 cm

Cervical dilatation 6 cm

Women with cervical dilatation 6 cm

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen genetically XX
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All women who fulfil the inclusion criteria

You may qualify if:

  • cervical dilatation 4 or 6 cm
  • singleton
  • cephalic presentation
  • at 37 weeks or more
  • normal cardiotocograph tracing on admission
  • understands Malay or English
  • no uterine scar
  • no pre-existing medical disorders
  • no antenatal complications such as diabetes or hypertension

You may not qualify if:

  • multiple pregnancy
  • none cephalic presentation
  • abnormal admission cardiotocograph tracing
  • less than 37 weeks gestation
  • refusal to participate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Canselor Tuanku Muhriz

Kuala Lumpur, Cheras, 56000, Malaysia

Location

MeSH Terms

Conditions

Pregnancy Complications

Condition Hierarchy (Ancestors)

Female Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Rahana Abd Rahman

    National University of Malaysia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

July 24, 2025

First Posted

August 13, 2025

Study Start

June 27, 2024

Primary Completion

February 28, 2025

Study Completion

February 28, 2025

Last Updated

August 13, 2025

Record last verified: 2025-08

Locations

MY(1)